Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre

doi:10.2807/1560-7917.ES.2018.23.7.18-00057

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

Primary Health Care Sentinel Network
, Network for Influenza Surveillance in Hospitals of Navarre

Trazabilidad circular

IdiSNA - Navarre Institute for Health Research
Navarre Institute for Health Research
Instituto de Salud Pública de Navarra
Instituto de Salud Carlos III
Hospital Reina Sofia
Hospital García Orcoyen

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

30 Citas (Scopus)

Resumen

The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.

Idioma original	Inglés
Número de artículo	18-00057
Publicación	Eurosurveillance
Volumen	23
N.º	7
DOI	https://doi.org/10.2807/1560-7917.ES.2018.23.7.18-00057
Estado	Publicada - 15 feb 2018

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.2807/1560-7917.ES.2018.23.7.18-00057

Interim effectiveness of trivalentLicencia: Sin especificar

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{efc38b64e6dc48e88547c89887c8580b,

title = "Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18",

abstract = "The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39\% (95\% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41\% for current and any prior doses, 67\% for current vaccination only, and 22\% for any prior doses, and 43\%, 51\% and 54\%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.",

author = "\{Primary Health Care Sentinel Network\} and \{Network for Influenza Surveillance in Hospitals of Navarre\} and Jes{\'u}s Castilla and Ana Navascu{\'e}s and Itziar Casado and Alejandra P{\'e}rez-Garc{\'i}a and Aitziber Aguinaga and Guillermo Ezpeleta and Francisco Pozo and Carmen Ezpeleta and Iv{\'a}n Mart{\'i}nez-Baz and I. Abad and P. Aldaz and R. Ansorena and I. Arc{\'e}iz and E. Arina and Arrechea, \{M. A.\} and I. Arribas and N. Azn{\'a}rez and Bartolom{\'e}, \{F. C.\} and A. Beguiristain and A. Beltr{\'a}n and M. Bidarte and I. Blanco and A. Brugos and B. Cano and Castresana, \{M. V.\} and Cenoz, \{J. C.\} and F. Cia and B. Compains and Corpas, \{J. R.\} and F. Cortes and B. Chur{\'i}o and Cuevas, \{P. C.\} and \{Da Costa\}, \{E. M.\} and D{\'i}ez, \{M. R.\} and Escribano, \{F. J.\} and M. Esparza and Esparza, \{M. J.\} and V. Etayo and \{Fern{\'a}ndez Alfaro\}, C. and B. Flamarique and Garc{\'e}s, \{M. L.\} and \{Garc{\'i}a Alb{\'e}niz\}, T. and \{Garc{\'i}a Nicol{\'a}s\}, \{F. J.\} and Germ{\'a}n, \{A. B.\} and A. Giner and Guiu, \{J. O.\} and Gurbindo, \{J. C.\} and Guruchaga, \{M. J.\} and Heras, \{J. A.\} and \{Hern{\'a}ndez Galindo\}, M.",

year = "2018",

month = feb,

day = "15",

doi = "10.2807/1560-7917.ES.2018.23.7.18-00057",

language = "English",

volume = "23",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "7",

}

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18. / Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre.
En: Eurosurveillance, Vol. 23, N.º 7, 18-00057, 15.02.2018.

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

TY - JOUR

T1 - Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

AU - Primary Health Care Sentinel Network

AU - Network for Influenza Surveillance in Hospitals of Navarre

AU - Castilla, Jesús

AU - Navascués, Ana

AU - Casado, Itziar

AU - Pérez-García, Alejandra

AU - Aguinaga, Aitziber

AU - Ezpeleta, Guillermo

AU - Pozo, Francisco

AU - Ezpeleta, Carmen

AU - Martínez-Baz, Iván

AU - Abad, I.

AU - Aldaz, P.

AU - Ansorena, R.

AU - Arcéiz, I.

AU - Arina, E.

AU - Arrechea, M. A.

AU - Arribas, I.

AU - Aznárez, N.

AU - Bartolomé, F. C.

AU - Beguiristain, A.

AU - Beltrán, A.

AU - Bidarte, M.

AU - Blanco, I.

AU - Brugos, A.

AU - Cano, B.

AU - Castresana, M. V.

AU - Cenoz, J. C.

AU - Cia, F.

AU - Compains, B.

AU - Corpas, J. R.

AU - Cortes, F.

AU - Churío, B.

AU - Cuevas, P. C.

AU - Da Costa, E. M.

AU - Díez, M. R.

AU - Escribano, F. J.

AU - Esparza, M.

AU - Esparza, M. J.

AU - Etayo, V.

AU - Fernández Alfaro, C.

AU - Flamarique, B.

AU - Garcés, M. L.

AU - García Albéniz, T.

AU - García Nicolás, F. J.

AU - Germán, A. B.

AU - Giner, A.

AU - Guiu, J. O.

AU - Gurbindo, J. C.

AU - Guruchaga, M. J.

AU - Heras, J. A.

AU - Hernández Galindo, M.

PY - 2018/2/15

Y1 - 2018/2/15

N2 - The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.

AB - The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.

UR - https://www.scopus.com/pages/publications/85043382214

U2 - 10.2807/1560-7917.ES.2018.23.7.18-00057

DO - 10.2807/1560-7917.ES.2018.23.7.18-00057

M3 - Article

C2 - 29471624

AN - SCOPUS:85043382214

SN - 1025-496X

VL - 23

JO - Eurosurveillance

JF - Eurosurveillance

IS - 7

M1 - 18-00057

ER -

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto